Study and Transformation of Tumor Molecular Features Screening Model of Endometrial Carcinoma Surgical Approach

1. Research purpose and significance Endometrial carcinoma is one of the three most common malignant tumors in gynecological diseases. At present, its emergence has caused a relatively serious health economic burden worldwide, according to statistics, the number of new cases of endometrial carcinoma in the world exceeded 400,000 in 2020. In China, the incidence of endometrial carcinoma is second only to cervical cancer and ranks second among female reproductive tract malignancies. In recent years, public health problems such hypertension, diabetes mellitus and poor lifestyle have become increasingly serious, which has led to an increase in the incidence of endometrial carcinoma and a younger age of onset.

The prognosis of patients with endometrial carcinoma is closely related to their clinicopathological features, such as stage, grade, and pathological subtype. Stratified individualized diagnosis and treatment of endometrial carcinoma patients is an important direction that international scholars have been constantly exploring. In 1983, Bohkman proposed the dichotomous classification systemof endometrial carcinoma, which is based on the pathological characteristics to divide endometrial carcinoma into two types, type I carcinoma into two types, of which type I cancer mainly refers to endometrioid adenocarcinoma, type II carcinoma includes serous carcinoma, clear cell carcinoma and other special types. However, further evidence suggests that this approach is still limited in guiding patients' management and outcome. In 2013, American scholars used he Cancer Genome Atlas data to further propose the molecular typing of endometrial carcinoma, which divided endometrial carcinoma into four categories: POLE (ultramutated)，microsatellite instability (MSI)hypermutated, Copy-number low(CNL) and Copy-number high(CNH). Among them, POLE (ultramutated)type has the best prognosis, CNH type has the worst prognosis, and the other two types are in the middle. Effective individualized diagnosis and treatment according to the clinicopathological and molecular characteristics of patients is a hot issue that international scholars are concerned about and is of great significance. At present, there are clinical trials related to postoperative adjuvant therapy based on molecular characteristics, and a large number of studies on targeted therapy and immunotherapy support the clinical application of related drugs，so far, research on molecular characteristics and endometrial carcinoma surgery is still in a state of scarcity.

In 2018, American scholars published a prospective and retrospective study on laparoscopic surgery for the treatment of early cervical carcinoma. The results suggest that the risk of recurrence and death in the minimally invasive surgery group is much higher than in the open surgery group, and the reasons are likely to include uterine lifting cup, the effects of laparoscopic CO2 pneumoperitoneum, or surgeon experience. It led the investigators to wonder whether similar factors would also have an impact on the safety of eminimally invasive surgery in endometrial carcinoma. Furthermore, regarding the choice of the endometrial carcinoma surgical route, although large-scale clinical trials have demonstrated that the prognosis of patients after minimally invasive surgery and open surgery is similar, the current study did not include patient molecular characteristics. According to the clinicopathological and molecular characteristics of patients, the formulation of personalized surgical strategies suitable for different groups of people is an important clinical problem that needs to be solved urgently.

This project is based on theresults of previous retrospective studies of this research group, so as to carry out prospective randomized controlled studies, further evaluate the impact of surgical approaches on the prognosis of patients with endometrial cancer with different molecular characteristics, establish a clinical application model based on molecular characteristics to guide the selection of surgical routes, and transform it into a clinical decision-making technical index system for endometrial cancer surgical selection based on molecular characteristics for further promotion and application. 2. The research status at home and abroad After TCGA endometrial carcinoma molecular typing was proposed in 2013, many international research teams further simplified it, which greatly promoted the clinical promotion and application of molecular typing. The existing endometrial carcinoma typing system includes the PromisE classification proposed by Canadian scholars, TranPORTEC typing proposed by Dutch scholars. Based on this, the researchers carried out further work on molecular characteristics to guide patients with postoperative adjuvant therapy. Recently, Dutch scholars have further analyzed the effects of different molecular characteristics on the efficacy of adjuvant chemoradiotherapy in high-risk endometrial carcinoma patients based on PORTEC3 research data ，and are designing a prospective randomized controlled trial (i.e., PORTEC-4a study) based on TransPORTEC classification guidance for postoperative adjuvant radiotherapy in patients with high-risk endometrial carcinoma. Recently, Korean scholars published an analysis on the efficacy of PromisE typing and fertility preserving treatment of endometrial cancer. The above studies show that patients with different molecular characteristics respond differently to different therapeutic measures, so further establishing individualized diagnosis and treatment strategies for patients with different subtypes is an important direction for future research.

Surgery is the most important part of the endometrial carcinoma complex. Moreover, the application of minimally invasive techniques significantly reduced the incidence of perioperative complications, reduced intraoperative blood loss, and shortened the average length of hospital stay，but the long-term safety of this technique is still an important issue worthy of further investigation. Although clinical trials have confirmed that the long-term prognosis of minimally invasive surgery for early endometrial carcinoma is similar to that of open surgery，none of the above studies included the molecular characteristics of patients. In recent years, more and more research evidence has shown the importance of molecular characteristics in the prognosis and stratified management of endometrial carcinoma patients, so it is necessary to further evaluate and analyze the prognosis of endometrial carcinoma patients with different molecular characteristics after minimally invasive surgery.